pd 138312 has been researched along with imipenem, anhydrous in 1 studies
| Studies (pd 138312) | Trials (pd 138312) | Recent Studies (post-2010) (pd 138312) | Studies (imipenem, anhydrous) | Trials (imipenem, anhydrous) | Recent Studies (post-2010) (imipenem, anhydrous) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 4,784 | 391 | 1,397 |
| Protein | Taxonomy | pd 138312 (IC50) | imipenem, anhydrous (IC50) |
|---|---|---|---|
| Beta-lactamase | Pseudomonas aeruginosa | 0.15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, MA; Dazer, ME; Domagala, JM; Huband, MD; Meservey, MA; Roland, GE; Yoder, SL | 1 |
1 other study(ies) available for pd 138312 and imipenem, anhydrous
| Article | Year |
|---|---|
In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Topoisomerase II Inhibitors | 1993 |